EBOLA IN DRC: OVER 1,100 SUSPECTED CASES, SUSPECTED CASES RULED OUT IN BRAZIL AND ITALY, TEDROS WRAPS UP KINSHASA VISITCOMPARATIVE VIEW
EXPLORE THIS STORY
SHARE THIS COMPARISON
Show your friends how the world sees the same news differently.
The Bundibugyo outbreak in Ituri crosses 1,100 suspected cases and 263 confirmed; Tedros leaves Tshisekedi in Kinshasa; Brazil and Italy rule out their first suspects; Nanyuki erupts against the US quarantine base imposed by Washington in Kenya.
🇧🇪 Belgique vs 🇦🇺 Australia
FRAMING GAP
89/100HIGH
Perspectives diverge strongly
Here are the main framing differences identified between media coverages.
ANALYSIS BY COUNTRY
AUSTRALIADOMINANT ANGLE
Canberra follows the vaccine race (rVSV, ChAdOx1, mRNA) and tallies the delay on Bundibugyo dormant since 2013
Dominant angle identified — does not reflect unanimity of this country’s media
KEY POINTS
- •ABC News reveals that Geisbert's rVSV candidate protected against Bundibugyo as early as 2013 but remained dormant due to lack of pharmaceutical interest
- •The WHO estimates a minimum 7-9 month delay for human trials of rVSV, and Gavi allocates up to $50M additional for production
- •PerthNow notes that China has announced the sending of a team of medical specialists to the DRC, a sanitary influence signal that Canberra is watching attentively
BIASES
Scientific pragmatism: Australian coverage prioritizes technical details over political or humanitarian narrativesReading of sanitary power dynamics: the sending of Chinese medical teams is noted as a geopolitical move without condemnationEmotional distance: no local Congolese voice is cited, the crisis is read from laboratories and ministries
BELGIQUEDOMINANT ANGLE
Belgium relays from Antwerp the words of a Flemish doctor from the Institute of Tropical Medicine who arrived in Bunia: 'the virus is deeply rooted'
Dominant angle identified — does not reflect unanimity of this country’s media
KEY POINTS
- •Dr. Laurens Liesenborghs (Antwerp Institute of Tropical Medicine) arrived in Bunia with his team and describes a virus 'deeply rooted'
- •The testing capacity in Bunia has risen from 40 to 300 per day thanks to the reagents delivered, but only 20% of high-risk contacts are followed up
- •The Belgian team will test a treatment already validated in the lab on animals to try to reduce human mortality
BIASES
Historical post-colonial filiation: the coverage inscribes Belgian expertise in the continuity of Ebola 1976 without questioning the conditions of the current partnershipCentering on the Western doctor sent: the local Congolese voice (patients, families, caregivers) remains secondary to that of the specialist from AntwerpTechnical sobriety: the story prioritizes testing capacity numbers over the political and security context in which the ITM operates in Bunia
BELGIQUEDOMINANT ANGLE
Belgium relays from Antwerp the words of a Flemish doctor from the Institute of Tropical Medicine who arrived in Bunia: 'the virus is deeply rooted'
Dominant angle identified — does not reflect unanimity of this country’s media
KEY POINTS
- •Dr. Laurens Liesenborghs (Antwerp Institute of Tropical Medicine) arrived in Bunia with his team and describes a virus 'deeply rooted'
- •The testing capacity in Bunia has risen from 40 to 300 per day thanks to the reagents delivered, but only 20% of high-risk contacts are followed up
- •The Belgian team will test a treatment already validated in the lab on animals to try to reduce human mortality
BIASES
Historical post-colonial filiation: the coverage inscribes Belgian expertise in the continuity of Ebola 1976 without questioning the conditions of the current partnershipCentering on the Western doctor sent: the local Congolese voice (patients, families, caregivers) remains secondary to that of the specialist from AntwerpTechnical sobriety: the story prioritizes testing capacity numbers over the political and security context in which the ITM operates in Bunia
AUSTRALIADOMINANT ANGLE
Canberra follows the vaccine race (rVSV, ChAdOx1, mRNA) and tallies the delay on Bundibugyo dormant since 2013
Dominant angle identified — does not reflect unanimity of this country’s media
KEY POINTS
- •ABC News reveals that Geisbert's rVSV candidate protected against Bundibugyo as early as 2013 but remained dormant due to lack of pharmaceutical interest
- •The WHO estimates a minimum 7-9 month delay for human trials of rVSV, and Gavi allocates up to $50M additional for production
- •PerthNow notes that China has announced the sending of a team of medical specialists to the DRC, a sanitary influence signal that Canberra is watching attentively
BIASES
Scientific pragmatism: Australian coverage prioritizes technical details over political or humanitarian narrativesReading of sanitary power dynamics: the sending of Chinese medical teams is noted as a geopolitical move without condemnationEmotional distance: no local Congolese voice is cited, the crisis is read from laboratories and ministries
AI-generated content — Analyses are produced by artificial intelligence from press articles. They may contain errors or biases. Learn more